Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Immunotherapy a New Hope for Cancer Treatment: A Review Publisher Pubmed



Rouzbahani FN1 ; Shirkhoda M1 ; Memari F1 ; Dana H1, 2 ; Chalbatani GM1 ; Mahmoodzadeh H1 ; Samarghandi N3 ; Gharagozlou E1 ; Hadloo MHM4 ; Maleki AR1 ; Sadeghian E1 ; Nia EZ2 ; Nia N5 ; Hadjilooei F1 Show All Authors
Authors
  1. Rouzbahani FN1
  2. Shirkhoda M1
  3. Memari F1
  4. Dana H1, 2
  5. Chalbatani GM1
  6. Mahmoodzadeh H1
  7. Samarghandi N3
  8. Gharagozlou E1
  9. Hadloo MHM4
  10. Maleki AR1
  11. Sadeghian E1
  12. Nia EZ2
  13. Nia N5
  14. Hadjilooei F1
  15. Rezaeian O6
  16. Meghdadi S6
  17. Miri S1
  18. Jafari F7
  19. Rayzan E8
  20. Marmari V2

Source: Pakistan Journal of Biological Sciences Published:2018


Abstract

Cancer is a major burden of disease worldwide with considerable impact on society. The tide of immunotherapy has finally changed after decades of disappointing results and has become a clinically validated treatment for many cancers. Immunotherapy takes many forms in cancer treatment, including the adoptive transfer of ex vivo activated T cells, oncolytic viruses, natural killer cells, cancer vaccines and administration of antibodies or recombinant proteins that either costimulate cells or block the so-called immune checkpoint pathways. Recently, cancer immunotherapy has received a high degree of attention, which mainly contains the treatments for programmed death ligand 1 (PD-L1), programmed death 1 (PD-1), chimeric antigen receptors (CARs) and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). Here, this paper reviewed the current understandings of the main strategies in cancer immunotherapy (adoptive cellular immunotherapy, immune checkpoint blockade, oncolytic viruses and cancer vaccines) and discuss the progress in the synergistic design of immune-targeting combination therapies. © 2018 Fatemeh Nouri Rouzbahani et al.
Related Docs
View other Related Docs
1. Immunologic Tumor Microenvironment Modulators for Turning Cold Tumors Hot, Cancer Communications (2024)
2. Nivolumab Plus Ipilimumab Combination Therapy in Cancer: Current Evidence to Date, International Immunopharmacology (2023)
3. Mesenchymal Stem Cell-Released Oncolytic Virus: An Innovative Strategy for Cancer Treatment, Cell Communication and Signaling (2023)
Experts (# of related papers)
View all Related Experts
Ilnaz Rahimmanesh (4)
Mazdak Ganjalikhani Hakemi (3)
Other Related Docs
4. Gene-Knocked Out Chimeric Antigen Receptor (Car) T Cells: Tuning up for the Next Generation Cancer Immunotherapy, Cancer Letters (2018)
5. Cancer Vaccine in Cold Tumors: Clinical Landscape, Challenges, and Opportunities, Current Cancer Drug Targets (2022)
6. Oncolytic Virus Delivery Modulated Immune Responses Toward Cancer Therapy: Challenges and Perspectives, International Immunopharmacology (2022)
7. Immune Checkpoint Inhibition for the Treatment of Cancers: An Update and Critical Review of Ongoing Clinical Trials, Clinical Immunology (2021)
8. Investigating the Dynamic Interplay Between Cellular Immunity and Tumor Cells in the Fight Against Cancer: An Updated Comprehensive Review, Iranian Journal of Blood and Cancer (2024)
9. Identifying the Most Effective Hydatid Cyst Fluid Fraction for Anticancer Vaccination of 4T1 Breast Tumor-Bearing Mice, International Journal of Preventive Medicine (2019)
10. A Comprehensive Review on Novel Targeted Therapy Methods and Nanotechnology-Based Gene Delivery Systems in Melanoma, European Journal of Pharmaceutical Sciences (2023)
11. Targeting Immune Checkpoints: How to Use Natural Killer Cells for Fighting Against Solid Tumors, Cancer Communications (2023)
12. The Molecular Perspective on the Melanoma and Genome Engineering of T-Cells in Targeting Therapy, Environmental Research (2023)
13. Pd-L1 Importance in Malignancies Comprehensive Insights Into the Role of Pd-L1 in Malignancies: From Molecular Mechanisms to Therapeutic Opportunities, Clinical and Experimental Medicine (2025)
14. Clinical Combinatorial Treatments Based on Cancer Vaccines: Combination With Checkpoint Inhibitors and Beyond, Current Drug Targets (2022)
15. In Silico Analysis of Transmembrane Protein 31 (Tmem31)Antigen to Design Novel Multiepitope Peptide and Dna Cancer Vaccines Against Melanoma, Molecular Immunology (2019)
16. Exploring the Cancer-Testis Antigen Boris to Design a Novel Multi-Epitope Vaccine Against Breast Cancer Based on Immunoinformatics Approaches, Journal of Biomolecular Structure and Dynamics (2022)
17. The Role of Immune Regulatory Molecules in Multiple Sclerosis, Journal of Neuroimmunology (2019)
18. Enhanced in Vivo Anti-Tumor Efficacy of Whole Tumor Lysate in Combination With Whole Tumor Cell-Specific Polyclonal Antibody, Research in Pharmaceutical Sciences (2023)
19. Chimeric Antigen Receptor-T Cells Immunotherapy for Targeting Breast Cancer, Research in Pharmaceutical Sciences (2021)
20. The Role of Tim-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?, Frontiers in Oncology (2020)